Physician

Jonathan Obert, MD

According to 2025 Medicare claims, Jonathan Obert, MD (NPI: 1063703007) practices gastroenterology in the Louisville/Jefferson County, KY-IN market, with the plurality of this provider's patient population coming from Clark, IN. This provider's primary affiliated billing organization is GASTROENTEROLOGY HEALTH PARTNERS, PLLC (NPI: 1982963872; TIN: 454217766) and primary practice location at 47150-4053.

Obert's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 765 traditional Medicare patients, billed 19,214 HCPCS/CPT codes, and received $401,488 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,352 prescription claims across 327 beneficiaries totaling $1,345,801 in drug costs, led by Skyrizi On-Body (Risankizumab-Rzaa). Open Payments data shows 238 records totaling $178,813. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $74,076 to $401,488. Similarly, Part D prescription costs have moved sharply higher in recent years, from $344,211 to $1,345,801. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	192	4,255	$74,076
2018	775	17,168	$327,667
2019	843	12,713	$307,570
2020	672	11,015	$270,160
2021	647	14,205	$300,377
2022	780	17,289	$403,204
2023	674	15,660	$315,626
2024	765	19,214	$401,488

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	24	95	$344,211
2016	17	34	$1,607
2017	51	143	$9,488
2018	172	615	$289,139
2019	252	1,114	$242,681
2020	272	1,165	$382,028
2021	282	1,287	$354,716
2022	329	1,551	$380,043
2023	307	1,444	$336,494
2024	327	1,352	$1,345,801

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	141	142	$169
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	101	101	$99
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	175	179	$92
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	193	312	$55
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	193	199	$53

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Skyrizi On-Body	Risankizumab-Rzaa	20	1,120	$412,013
Humira(Cf) Pen	Adalimumab	12	336	$161,500
Rinvoq	Upadacitinib	19	564	$135,119
Xifaxan	Rifaximin	36	1,178	$121,983
Creon	Lipase/Protease/Amylase	24	1,239	$70,831

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	230	$118,298	Phathom Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	8	$60,515	Teva Pharmaceuticals USA, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jonathan Obert, MD?

Tedicare shows public-source Medicare data for Jonathan Obert, MD (NPI 1063703007), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jonathan Obert, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jonathan Obert, MD?

Jonathan Obert, MD is linked to GASTROENTEROLOGY HEALTH PARTNERS, PLLC (billing NPI 1982963872) in the available physician profile data.

Does Jonathan Obert, MD have Open Payments data?

Jonathan Obert, MD has 238 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.